50222-361-02 : NDC 2026 Code

50222-361-02 : Spesolimab ( Spevigo )

Additionally :

You can get information about “50222-361-02” NDC code in 50222-361-02 in HTML format

HTML | 50222-361-02 in TXT (Plain Text) format

TXT | 50222-361-02 in PDF (Portable Document Format)

PDF | 50222-361-02 in XML format

XML formats.

NDC Code : 50222-361-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "50222-361-02",
    "PackageDescription": "2 SYRINGE, GLASS in 1 CARTON (50222-361-02)  / 1 mL in 1 SYRINGE, GLASS (50222-361-11) ",
    "NDC11Code": "50222-0361-02",
    "ProductNDC": "50222-361",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Spevigo",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Spesolimab",
    "DosageFormName": "INJECTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20260309",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761244",
    "LabelerName": "LEO Pharma Inc.",
    "SubstanceName": "SPESOLIMAB",
    "StrengthNumber": "150",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Interleukin-36 Receptor Antagonist [EPC], Interleukin-36 Receptor Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-03-19",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260309",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}